Coimunoprecipitation (IP) using antibodies against BIP/GRP78 was performed to investigate the dissociation of the BIP/GRP78-PERK and BIP/GRP78-IRE1α complexes in JI017-treated prostate cancer cells. This evidence concerns the gene HSPA5 and prostate carcinoma.